Self-care tech startup Boulevard just raised $80M in Series D funding, boosting its valuation to nearly $800M. Originally built to help salons manage online bookings, the platform now powers 15% of U.S. medspas, offering tools like HIPAA-compliant injection mapping and payment processing. With beauty and wellness services expanding into medical territory—like Botox and GLP-1 weight loss meds—Boulevard’s client base and revenue (up 500% in 3 years) are growing fast. Led by JMI Equity, this round shows investor confidence in Boulevard’s niche in the booming medspa market.
Credit: TechCrunch
